@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0030705 "patients";
ns1:C0205210 "clinical";
ns1:C0231218 "ill";
ns1:C0282440 "randomized controlled trials";
ns1:C3272565 "clinical" .
rdf:predicate ns3:TRIPLE_UID:gvu30egy-TRIPLE-ABSTRACT-1 "demonstrate" .
rdf:subject ns1:C0011777 "dexamethasone";
ns1:C0087111 "treatments";
ns1:C4726677 "remdesivir" .
rdfs:Triple-UID ns2:TRIPLE_UID:gvu30egy-TRIPLE-ABSTRACT-1 "gvu30egy-TRIPLE-ABSTRACT-1" .
rdfs:sentence rdfs:label "To date, only two treatments, remdesivir and dexamethasone, have demonstrated clinical efficacy through randomized controlled trials (RCTs) in seriously ill patients." .
rdfs:triple rdfs:label "only two treatments , remdesivir and dexamethasone demonstrated clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:47:25.030430"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "en/IeyO2kZHD62n+EeTxDuNkIMXfD3MIMI+ZI/haVVNyx/CYegcTU3hiivwYkPnPsP76K4Lka80a1A+6XuLc9rdiPgHr7uV/GX5GlMe/DA+wWScbPlPlvmFmh7f84TxQQajg1a85HjKnpAA3IvISKLqe5noKN19IJwrRiC1pCls=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:47:25.030430"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}